Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02349139
Title Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Asana BioSciences
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center, Clark Urology Center Los Angeles California 90095 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Abramson Cancer Center, Hospital of the Univ. of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field